Recipients of the Johnson & Johnson COVID-19 vaccine were more likely to experience a rare blood clotting issue than persons in the general population before the pandemic, according to a study published Monday by JAMA Internal Medicine. Mayo Clinic researchers gathered data on rates of the clotting disorder in Olmsted ...
Google, News
Merkez mahallesi mutlu han sokak no:17/2 Bartın/Sakarya
info@wwwnews.com.tr